Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN360340 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Ribosomal Protein S6 Kinase, 90kDa, Polypeptide 1 (RPS6KA1) (Ser732) antibody
- Antibody type
- Polyclonal
- Antigen
- This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide corresponding to amino acid residues surrounding S732 of human RPS6KA1.
- Description
- Protein A column, followed by peptide affinity purification
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- Ser732
- Vial size
- 0.4 mL
- Concentration
- 0.25 mg/mL
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at-20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references 14-3-3beta is a p90 ribosomal S6 kinase (RSK) isoform 1-binding protein that negatively regulates RSK kinase activity.
Inorganic lead activates the mitogen-activated protein kinase kinase-mitogen-activated protein kinase-p90(RSK) signaling pathway in human astrocytoma cells via a protein kinase C-dependent mechanism.
Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E.
VIIa/tissue factor interaction results in a tissue factor cytoplasmic domain-independent activation of protein synthesis, p70, and p90 S6 kinase phosphorylation.
Cavet ME, Lehoux S, Berk BC
The Journal of biological chemistry 2003 May 16;278(20):18376-83
The Journal of biological chemistry 2003 May 16;278(20):18376-83
Inorganic lead activates the mitogen-activated protein kinase kinase-mitogen-activated protein kinase-p90(RSK) signaling pathway in human astrocytoma cells via a protein kinase C-dependent mechanism.
Lu H, Guizzetti M, Costa LG
The Journal of pharmacology and experimental therapeutics 2002 Mar;300(3):818-23
The Journal of pharmacology and experimental therapeutics 2002 Mar;300(3):818-23
Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E.
Fingar DC, Salama S, Tsou C, Harlow E, Blenis J
Genes & development 2002 Jun 15;16(12):1472-87
Genes & development 2002 Jun 15;16(12):1472-87
VIIa/tissue factor interaction results in a tissue factor cytoplasmic domain-independent activation of protein synthesis, p70, and p90 S6 kinase phosphorylation.
Versteeg HH, Sørensen BB, Slofstra SH, Van den Brande JH, Stam JC, van Bergen en Henegouwen PM, Richel DJ, Petersen LC, Peppelenbosch MP
The Journal of biological chemistry 2002 Jul 26;277(30):27065-72
The Journal of biological chemistry 2002 Jul 26;277(30):27065-72
No comments: Submit comment
No validations: Submit validation data